Asia Pacific Blood Irradiation Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, and Others), and End User (Hospitals, Blood Banks, Diagnostics Clinics, and Research Institutes)
The blood irradiation market in Asia Pacific is expected to grow from US$ 7.48 million in 2022 to US$ 12.34 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028.
Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma Provide Opportunities for Market Growth
Immunity plays an important role in the well-being of every individual, and its status continues to fluctuate with age, lifestyle, and food habits. There has been significant growth in the immunocompromised population, particularly in developed economies. An increase in the cases of autoimmune disorders, Human Immunodeficiency Virus (HIV) infections, organ transplants, etc., and the increased use of immunosuppressants are among the major factors leading to the hike in this population. Moreover, there has been significant growth in leukemia and lymphoma incidence rates. Such a rise in the immunocompromised population and the rising prevalence of autoimmune disorders are expected to create ample opportunities for companies in the blood irradiation market in the coming years.
Market Overview
The Asia Pacific blood irradiation market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region is characterized by a mixed growth scenario, with some countries having complex macroeconomic and political environments. Nevertheless, positive initiatives by governments are bolstering economic growth in most of these countries. Developing economies such as China, India, and Indonesia are investing substantially in infrastructure and industrial developments. In Asia Pacific, China is the largest market for blood irradiation market. The growth of the market is primarily attributed to the growing healthcare industry, increasing developments by the market players, and favorable regulatory policies. Additionally, the excessive population in China coupled with the rise of blood related disorder prevalence is majorly driving the growth of the blood irradiation market in China and making it a prime market in the Asia Pacific region. Rapid socioeconomic progress has greatly affected the lifestyle in China. Consequently, owing to lifestyle changes, urbanization, and accelerated population aging, the risk of cardiovascular diseases (CVD) has increased. China had the highest number of heart disease deaths last year, followed by India, Russia, the United States and Indonesia. Thus, owing to huge patient population of various communicable and non-communicable diseases and research and development by the market players is expected to propel the demand of blood irradiation market in this country.
Asia Pacific Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Asia Pacific Blood Irradiation Market Segmentation
The Asia Pacific blood irradiation market is segmented into type , indication, end user, and country.
- Based on type, the Asia Pacific blood irradiation market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.
- Based on indication , the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.
- Based on end user, the Asia Pacific blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.
- Based on country, the market is segmented into China, Japan, India, Australia, South Korea and Rest of Asia Pacific. China dominated the market share in 2022.
Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in Asia Pacific.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Blood Irradiation Market – By Type
1.3.2 Asia Pacific Blood Irradiation Market – By Indication
1.3.3 Asia Pacific Blood Irradiation Market – By End User
1.3.4 Asia Pacific Blood Irradiation Market – By Country
2. Asia Pacific Blood Irradiation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Blood Irradiation Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific PEST Analysis
4.3 Experts Opinion
5. Asia Pacific Blood Irradiation Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Communicable and Noncommunicable Diseases
5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma
5.4 Future Trends
5.4.1 Technological Advancements and Product Launches
5.5 Impact Analysis
6. Blood Irradiation Market– Asia Pacific Analysis
6.1 Asia Pacific Blood Irradiation Market Revenue Forecasts and Analysis
6.1.1 Overview
6.1.2 Asia Pacific Blood Irradiation Market, and Forecast to 2028 (Units)
7. Asia Pacific Blood Irradiation Market Analysis – By Type
7.1 Overview
7.2 Asia Pacific Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
7.2.1 Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
7.3 Intravenous Laser Blood Radiation
7.3.1 Overview
7.3.2 Asia Pacific Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
7.4.1 Overview
7.4.2 Asia Pacific Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
7.5.1 Overview
7.5.2 Asia Pacific Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Blood Irradiation Market –By End User
8.1 Overview
8.2 Asia Pacific Blood Irradiation Market, by End User, 2021 and 2028 (%)
8.2.1 Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
8.3 Hospitals
8.3.1 Overview
8.3.2 Asia Pacific Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
8.4.1 Overview
8.4.2 Asia Pacific Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
8.5.1 Overview
8.5.2 Asia Pacific Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
8.6.1 Overview
8.6.2 Asia Pacific Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Blood Irradiation Market –By Indication
9.1 Overview
9.2 Asia Pacific Blood Irradiation Market, by Indication, 2021 and 2028 (%)
9.2.1 Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
9.3 Acute Leukemia
9.3.1 Overview
9.3.2 Asia Pacific Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
9.4.1 Overview
9.4.2 Asia Pacific Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
9.5.1 Overview
9.5.2 Asia Pacific Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
9.6.1 Overview
9.6.2 Asia Pacific Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Asia Pacific Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10. Asia Pacific Blood Irradiation Market – Country Analysis
10.1 Asia Pacific: Blood Irradiation Market
10.1.1 Overview
10.1.2 Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.1.2.1 China Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.1.4 China: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.1.5 China: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.2 Japan Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.2.4 Japan: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.2.5 Japan: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.3 India Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.3.4 India: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.3.5 India: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.4 South Korea Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 South Korea: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 South Korea: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.4.4 South Korea: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.4.5 South Korea: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.5 Australia Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 Australia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 Australia: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.5.4 Australia: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.5.5 Australia: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.2.6 Rest of Asia Pacific Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
11. Asia Pacific Blood Irradiation Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Asia Pacific Blood Irradiation Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Hitachi, Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Best Theratronics Ltd.,
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gilardoni S.p.A.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Typenex Medical
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Actemium
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Blood Irradiation Market– Volume and Forecast to 2028 (Units)
Table 2. Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Asia Pacific: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 4. Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. China Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 7. China Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. India Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. India Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 13. India Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 16. South Korea Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. Australia Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Australia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Asia Pacific Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. Recent Inorganic Growth Strategies in the Blood Irradiation Market
Table 24. Recent Organic Growth Strategies in the Blood Irradiation Market
Table 25. Glossary of Terms, Blood Irradiation Market
LIST OF FIGURES
Figure 1. Asia Pacific Blood Irradiation Market Segmentation
Figure 2. Asia Pacific Blood Irradiation Market Segmentation, By Region
Figure 3. Asia Pacific Blood Irradiation Market Overview
Figure 4. Intravenous Laser Blood Irradiation Segment Held Largest Share of Type Segment in Blood Irradiation Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Asia Pacific Blood Irradiation Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Blood Irradiation Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 10. Asia Pacific Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
Figure 11. Asia Pacific Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Asia Pacific Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Asia Pacific Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Asia Pacific Blood Irradiation Market, by End User, 2021 and 2028 (%)
Figure 15. Asia Pacific Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Asia Pacific Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asia Pacific Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Asia Pacific Blood Irradiation Market, by Indication, 2021 and 2028 (%)
Figure 20. Asia Pacific Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Asia Pacific Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Asia Pacific Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Asia Pacific Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Asia Pacific: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ Million)
Figure 26. Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 27. China: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Japan: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. India: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. South Korea: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Australia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies in the Asia Pacific Blood Irradiation Market, 2021-2028
- Hitachi, Ltd.
- Best Theratronics Ltd.,
- Gilardoni S.p.A.
- Typenex Medical
- Actemium
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Blood Irradiation Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Blood Irradiation Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.